45 Code Of Federal Regulations Part 46
45 Code Of Federal Regulations Part 46 outlines the ethical principles and regulatory requirements for research involving human subjects. These regulations are crucial for protecting the rights and welfare of individuals participating in research studies.

Key Takeaways
- 45 CFR Part 46 establishes federal protections for human subjects in research.
- It mandates Institutional Review Board (IRB) review and approval for most research.
- Key components include informed consent, risk-benefit assessment, and equitable subject selection.
- The regulations apply to all research funded or conducted by the U.S. Department of Health and Human Services (HHS).
- Compliance ensures ethical conduct and participant safety in clinical investigations.
What is 45 Code Of Federal Regulations Part 46 (45 CFR Part 46)?
45 Code Of Federal Regulations Part 46 (45 CFR Part 46) is a set of federal regulations governing research involving human subjects in the United States. These regulations are primarily enforced by the U.S. Department of Health and Human Services (HHS) and are designed to protect the rights, welfare, and well-being of individuals who participate in research studies. The core principles underlying 45 CFR Part 46 are derived from the Belmont Report, which emphasizes respect for persons, beneficence, and justice in research. A comprehensive 45 CFR Part 46 explanation highlights its role in establishing a robust framework for ethical research conduct across various scientific disciplines.
The primary goal of 45 CFR Part 46, often referred to as the “Common Rule” (specifically Subpart A), is to ensure that all research involving human subjects is conducted ethically and responsibly. This includes safeguarding participants from undue risks, ensuring their voluntary and informed consent, and promoting fair treatment throughout the research process. The regulations apply to research conducted or supported by HHS, as well as to institutions that voluntarily agree to comply with the Common Rule for all their human subjects research, regardless of funding source. This framework provides a clear 45 CFR Part 46 summary for researchers and institutions, detailing the minimum requirements for ethical research.
Key Regulations for Human Subject Research under 45 CFR Part 46
The human subject research regulations 45 CFR 46 outline several critical requirements that must be met before, during, and after a research study involving human participants. Central to these regulations is the mandate for review and approval by an Institutional Review Board (IRB). An IRB is an independent committee, typically composed of scientists, non-scientists, and community members, responsible for reviewing research proposals to ensure they meet ethical standards and protect the rights and welfare of human subjects.
Key aspects covered by 45 CFR Part 46 include:
- Institutional Review Board (IRB) Review: All research involving human subjects must be reviewed and approved by an IRB. The IRB assesses the research protocol, the informed consent process, and the potential risks and benefits to participants, ensuring that the study design is ethically sound.
- Informed Consent: Researchers must obtain legally effective informed consent from each prospective subject or their legally authorized representative. This process requires providing comprehensive information about the research, including its purpose, procedures, duration, risks, benefits, alternatives, and the right to withdraw, in a language understandable to the participant.
- Risk-Benefit Assessment: The IRB must determine that the risks to subjects are minimized to the extent possible and are reasonable in relation to anticipated benefits to subjects and the importance of the knowledge that may reasonably be expected to result from the research.
- Equitable Selection of Subjects: The selection of subjects must be equitable, considering the purposes of the research and the setting in which the research will be conducted. This principle aims to prevent the over-recruitment of vulnerable populations solely for convenience.
Furthermore, 45 CFR Part 46 includes specific subparts dedicated to additional protections for vulnerable populations. These include Subpart B for pregnant women, human fetuses, and neonates; Subpart C for prisoners; and Subpart D for children. These subparts impose extra safeguards to ensure that individuals who may be particularly susceptible to coercion or undue influence are adequately protected. Compliance with 45 CFR Part 46 is essential for maintaining public trust in research and for advancing medical and scientific knowledge responsibly, ensuring that all human subjects are treated with dignity and respect.



















